Nature Biotechnology |
| |
|
Contest spurs progress for programs that can map a brain cell's myriad branches.
|
| |
|
| The US National Nanotechnology Initiative has spent billions of dollars on submicroscopic science in its first 10 years. Corie Lok finds out where the money went and what the initiative plans to do next.
|
| |
|
| Automated synthesizers can make complex carbohydrates on demand.
|
| |
|
| Isolation of BRCA2 could help understanding of cancer risk and aid drug screening.
|
| |
|
| Decoy protein helps to fight cancer in mice by stopping muscle breakdown.
|
| |
|
| An ancient Chinese medicine might ease side effects of cancer treatments.
|
| |
|
| Researchers have rallied round a promising molecule for rescuing dying nerves. But getting it into the brain remains a daunting challenge, finds Brian Vastag.
|
| |
|
| Injunction raises questions over regulation.
|
| |
|
| Drugs do work as thought, says pharmaceutical giant.
|
| |
|
| Promising clinical trial results point to the pharmaceutical industry's next blockbuster.
|
| |
|
| A Russian court ruling favours housing over plant diversity.
|
| |
|
| Transgenic canola found growing freely in North Dakota.
|
| |
|
| Farmers and scientists struggle to keep up with needs of ambitious medicine-subsidy programme.
|
| |
|
| Coalition government promises to abolish respected regulator in effort to cut back on quangos.
|
| |
|
| John Savill will helm the UK Medical Research Council.
|
| |
|
|
| |